Skip to main content
MYNZ logo

Mainz Biomed B.V. (MYNZ) Stock Analysis

DELISTED

What happened to Mainz Biomed B.V. (MYNZ) stock?

Mainz Biomed B.V. (MYNZ) no longer trades on public markets. The figures below are historical and are not a current quote.

Status:
Delisted — no longer trades
MCap: $14.7M| Vol: 6.00M|

Market cap $14.7M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Mainz Biomed B.V. (MYNZ). Mainz Biomed B.V. specializes in molecular genetic diagnostics for cancer, developing in-vitro diagnostic tools and assays.

Last analyzed: Jun 15, 2026
Mainz Biomed B.V. specializes in molecular genetic diagnostics for cancer, developing in-vitro diagnostic tools and assays. Its primary offerings include ColoAlert for colorectal cancer screening and PancAlert, a product candidate for pancreatic cancer screening, alongside GenoStrip for pathogen identification.

Mainz Biomed B.V. (MYNZ) Healthcare & Pipeline Overview

Model self-rating on this text: 68% (not a measure of the evidence) Updated: Jun 15, 2026

More about this archive record

Can I still buy MYNZ shares?

No. MYNZ stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for MYNZ elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before MYNZ stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Mainz Biomed B.V.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: .

Data provided for informational purposes only.